Mutational and Structural Analysis of KIR3DL1 Reveals a Lineage-Defining Allotypic Dimorphism That Impacts Both HLA and Peptide Sensitivity
Geraldine M O'Connor, Julian P Vivian, Jacqueline M Widjaja, John S Bridgeman, Emma Gostick, Bernard AP Lafont, Stephen K Anderson, David A Price, Andrew G Brooks, Jamie Rossjohn, Daniel W McVicar
Journal of Immunology | AMER ASSOC IMMUNOLOGISTS | Published : 2014
Awarded by Frederick National Laboratory for Cancer Research, National Institutes of Health
Awarded by Worldwide Cancer Research
This work was supported by the Intramural AIDS Targeted Antiviral Program of the National Institutes of Health, the National Health and Medical Research Council of Australia, the Association for International Cancer Research (to A. G. B. and J.R.), and the Intramural Research Program of the National Institutes of Health, National Cancer Institute, National Institute of Allergy and Infectious Diseases, and federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health, under Contract HHSN26120080001E. J.P.V. is an Australian Research Council Discovery Early Career Researcher Award Fellow, D. A. P. is a Wellcome Trust Senior Investigator, and J.R. is a National Health and Medical Research Council of Australia Fellow.